With a 125-year history of developing lifesaving medicine, New Jersey is home to discovery.
Research, talent, funding, available space, university partnerships and industry expertise – New Jersey has it all for life sciences companies.
Home to 12 of the top 20 pharmaceutical companies, you’ll be in good company. A number of industry leaders have started here, including Celgene (a trailblazer in oncology), Amicus Therapeutics (which received its first FDA approval for rare diseases in 2018), NPS Pharma (bought by Shire for $5.2 billion in 2015) and Celator Pharmaceuticals (acquired by Jazz for $1.5 billion in 2016).
We have the brain power to build your business. New Jersey has the largest concentration of scientists and engineers per square mile than anywhere else in the world – 225,000 and counting. With nearly 3,300 facilities operating across all sectors, the New Jersey life sciences industry directly employs over 117,000 people, second only to California (with a population 30x larger).
No matter the size of your company, New Jersey will greet you at every stage of growth. From incubators to stand alone laboratory space at research parks and hubs, you’ll find the support you need here, along with world-class research universities, medical schools and some of the best hospitals in the country.
Join us in shaping human health for tomorrow’s world.
Employed biochemists and biophysicists
The world’s highest concentration per square mile
Pharmaceutical companies in the world
Let New Jersey be your gateway to the Northeast. We’re home to 21 Fortune 500 companies and 270 foreign national U.S. headquarters. New Jersey is the fourth largest state for incoming foreign direct investment.
Our central location and infrastructure will get you to where you want to go. A location in New Jersey offers easy access to financial markets and regulatory centers. Northern New Jersey is less than 20 minutes away from Manhattan and Washington D.C. is 3 hours away by train. New Jersey is located in the middle of the Boston – New York City – Washington D.C. corridor, one of the world’s most concentrated and affluent markets with 56.5 million residents and $3.75 trillion in economic output.
With the busiest seaport on the East Coast and one of the busiest airports in America, New Jersey moves people and products like no other state. Newark Liberty International Airport offers daily flights to nearly 175 non-stop destinations and services more than 130 international cities non-stop.
Multiculturalism is our strength and makes innovation truly possible. We are the fourth most diverse state in the nation with a 45% minority population and the third-largest foreign-born population. Our state is home to the #1 Most Diverse U.S. City (Jersey City) and the #1 U.S. City for Integrating Immigrants (Newark). We award more H-1B visas (total and per 100 workers) than Boston, MA, Austin, TX, and Raleigh, NC.
New Jersey offers companies an ever-growing pool of STEM talent and sets the standard for educating the next generation of visionaries. Our higher education institutions turn out 27,000 life sciences graduates every year. Six of these research universities—including #1 ranked Princeton University and Big Ten Academic Alliance member Rutgers University—offer graduate and postgraduate degrees in biomedical and healthcare fields.
From pre-school to graduate school, we invest in our students to help us build the foundation for innovation. New Jersey ranks #2 for educating students at every level and is home to High Technology High School in Lincroft—the #1 STEM high school in the country.
Trust New Jersey to get your product to market. We’re home to 12 of the world’s top companies for R&D productivity. The Northern New Jersey-New York MSA spends 20% more on R&D than Boston, MA, Austin, TX, and Raleigh, NC.
From lab to shelf, New Jersey’s diverse and expansive life sciences ecosystem has the support, funding and resources needed for success. More than 400 contract research organization (CROs) and 120 contract manufacturing companies are located here. We rank #2 for patents and #3 region for NIH funding.
The concentration of our research hospitals, medical schools and universities, combined with the State’s population density, multicultural diversity and transportation infrastructure makes New Jersey a perfect location for clinical trials. Today, there are more than 2,300 open and active trials underway.
Our state has the highest concentration of specialized commercialization expertise in the U.S.
Nearly 23,000 members of the State’s life sciences cluster are focused on pharmaceutical manufacturing—that’s 3x the national average.
In 2017 alone, companies with a footprint in New Jersey represented nearly 50 percent of all new FDA drug and therapy approvals, including, the first two FDA CAR T approvals, which represent a new era in cancer treatment, and the first FDA approval of a digital medicine system.
Calling all entrepreneurs: it’s easy to test new ideas here. New Jersey’s life sciences incubators offer companies access to both wet and dry labs, as well as a variety of support services, technical assistance, access to funding and mentoring to help you grow. With more than 8.3 million square feet of lab space available, New Jersey is ready to accommodate biotech companies from incubators to intermediate and stand-alone space at research parks and hubs. Read more about New Jersey’s innovation ecosystem and support for young life sciences companies here.
(Jersey City & Newark)
Have a presence in NJ
New Jersey companies are saving lives. Pharma powerhouses like Eisai, Novartis, Eli Lilly, J&J and Allergan are leading the way in the treatment and prevention of Alzheimer’s disease while Celgene, Pfizer, Bristol-Myers Squibb, Merck and Novartis are improving the lives of cancer patients around the world. Today, there are more than 1,000 drugs in development in New Jersey.
The best talent is concentrated here. The Newark-Jersey City metro area ranks #1 for Pharmaceutical Employment.
|15||Johnson & Johnson|
Source: Pharmaceutical Executive, 2018
New Jersey companies are pioneering patient-centric therapies. Our biotech community has grown by more than 400% in less than 2 decades and we’re ranked the #2 State for Bioscience Strength.
New Jersey’s universities are doubling down on their commitment to accelerate cell and gene therapy breakthroughs. Rutgers University’s RUCDR Infinite Biologics is the world’s largest university-based cell and DNA repository that collaborates with researchers in the public and private sectors throughout the world. The New Jersey Innovation Institute (NJII) is home to five industry-facing “innovationLabs” (iLabs), including the Cell and Gene Therapy Development Center (CGTDC), which combines state-of-the-art technologies, infrastructure, facilities and world-class expertise to support the development and manufacturing of cell therapy products.
|3||Bracco Diagnostics, Inc.|
|4||Cancer Genetics, Inc.|
New Jersey is on the forefront of next-gen medical devices, from neuro-stimulators to robotic assistance and implantable electronic devices. New Jersey’s medical device industry employs over 24,000 people at 700 establishments and accounts for 20% of the life sciences industry cluster’s employment. Despite having only 2% of the U.S. population, New Jersey employs 14% of medical device workers in the country.
Strong collaboration between New Jersey’s 13 teaching hospitals, 5 medical schools, and 7 research universities has allowed companies located here to bring disruptive technologies to market. From research to talent recruitment, New Jersey’s nationally ranked healthcare system – including Hackensack Meridian Health, our State’s largest and most comprehensive and integrated health network – stands ready to support the private sector.
Calling all entrepreneurs: it’s easy to test new ideas here. New Jersey’s life sciences incubators offer companies access to both wet and dry labs, as well as a variety of support services, technical assistance, and access to funding and mentoring to help you grow.
With 18.2 million square feet of lab inventory space available, New Jersey is ready to accommodate biotech companies from incubators to intermediate and stand-alone space at research parks and hubs. Read more about New Jersey’s innovation ecosystem and support for young life sciences companies on the NJ Buzz Blog.
|wdt_ID||Asset Class||New Jersey||California||Massachusetts||North Carolina||New York|
|1||Class A Office Space||$31.78 (North) $28.50 (Central) $24.16 (South)||$71.24 (San Francisco) $39.72 (Los Angeles) $39.24 (San Diego)||$60.45 (Cambridge)||$25.1 (Raleigh - Durham)||$78.43 (Manhattan)|
|2||Lab||$30.00 (North & Central)||$57.84 (San Francisco) $47.40 (San Diego) $30.67 (Los Angeles)||$74.88 (Cambridge)||$28.5 (Raleigh - Durham)||$27.30 (Manhattan & Brooklyn)|
|3||Flex/R&D||$11.28 (North & Central)||$17.28 (San Diego) $13.08 (Silicon Valley) $12.60 (Los Angeles)||N/A||$11.00 (Raleigh)||N/A|
New Jersey offers a number of attractive incentives for qualified life sciences companies, including
incentives specifically created to support start-up and early stage ventures.
This incentive gives biotech companies the ability to sell their net operating tax losses and R&D tax credits.Learn More
Emerging life sciences companies can gain access to angel and venture capital investors.Learn More
Provides refundable tax credits against New Jersey corporation business or gross income tax.Learn More
Provides growth capital to early-stage technology and life sciences companies.Learn More
We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.
We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.
Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.